Anna Unseld

Boehringer Ingelheim (Germany)1 paperOpenAlex

Papers

The New England Journal of MedicineHuman trial

Survodutide reduces weight in adults with diabetes and obesity

Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.Weekly survodutide cut body weight by up to 9.8% at 76 weeks compared to a 3.9% reduction with placebo.